跳至主要內容

藥物交互作用

Blinatumomab + Siponimod

嚴重程度: 中度

Blinatumomab and Siponimod: moderate interaction.

最後更新

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

摘要

Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

用白話說明這項交互作用的意義

Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Blinatumomab belongs to Oncology; Siponimod belongs to Central Nervous System.

證據等級: Low

為什麼會發生

Additive immune suppression from B-cell depletion and S1P-mediated lymphocyte sequestration.

處置方式

Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

可向藥師詢問的問題

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可解鎖 Blinatumomab 與 Siponimod 的完整臨床處置建議、補充說明、證據詳情及整張處方的交互作用檢查工具。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

在網頁版免費試用 Pro+ 14 天,無需信用卡。

常見問題

Can I take Blinatumomab with Siponimod?

MediHelp rates the interaction as moderate. Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

How serious is the interaction between Blinatumomab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥物交互作用

取得 App 登入